Logo for Big Heart pet brands.

Big Heart Pet Brands to be Acquired by The J.M. Smucker Company

(SAN FRANCISCO) February 3, 2015 – Big Heart Pet Brands today announced that it has entered into a definitive agreement to be acquired by The J.M. Smucker Company (“Smucker”) (NYSE: SJM), in a cash and stock transaction valued at approximately $5.8 billion. The transaction is expected to close by the end of Big Heart Pet Brands’ current fiscal year, which ends on May 3, 2015, subject to customary closing conditions including receipt of required regulatory approvals.

“We are pleased to join the Smucker Company and their family of iconic brands,” said Dave West, President and Chief Executive Officer of Big Heart Pet Brands. “Given the strong alignment between Big Heart Pet Brands’ and Smucker’s purposes and values, I’m confident that Smucker is a great fit for our brand portfolio. Our sponsor owners have been great partners as we invested in growing our business and capabilities to drive value creation, and our iconic pet food and snack brands have significant growth potential. Smucker will provide the resources and scale to help our brands continue to grow and flourish.”

Big Heart Pet Brands is headquartered in San Francisco, California and is currently owned by a consortium of investors led by funds affiliated with Kohlberg Kravis Roberts & Co. L.P. (“KKR”), Vestar Capital Partners (“Vestar”) and Centerview Capital (“Centerview”).

Big Heart Pet Brands changed its name from Del Monte Corporation following the divestiture of its Consumer Products business and namesake Del Monte brand on February 18, 2014. On March 8, 2011, Del Monte Foods was acquired and taken private by KKR, Vestar and Centerview.

"The teamwork between our private equity partners and the Big Heart Pet Brands management team has grown and strengthened Big Heart Pet Brands’ leadership in the dynamic pet food category," said a senior executive group from KKR, Vestar and Centerview. "Innovation and exciting new products, combined with enhanced support of its flagship brands, has positioned Big Heart Pet Brands for additional success. We owe a depth of gratitude to Dave West and the entire Big Heart Pet Brands team, who have built a best-in-class pet food and snacks company. We're confident that Big Heart Pet Brands can look ahead to continued success in the sector as part of the Smucker family. We look forward to benefiting from this synergistic combination as a meaningful shareholder in Smucker going forward."

Transaction Details

Under the terms of the agreement, Big Heart Pet Brands’ shareholders will receive 17.9 million shares of Smucker common stock and $1.3 billion in cash. Smucker will also refinance $2.6 billion of Big Heart Pet Brands’ debt.

Upon close of the transaction, Dave West will serve as president of Smucker’s new pet food business.

Smucker is a leading marketer and manufacturer of fruit spreads, retail packaged coffee, peanut butter, shortening and oils, ice cream toppings, sweetened condensed milk, and natural foods products in North America. Its family of brands includes Smucker's,® Folgers,® Dunkin' Donuts,® Jif, ® Crisco,® Pillsbury,® Eagle Brand,® R.W. Knudsen Family,® Hungry Jack,® Millstone,® Cafe Bustelo,® Café Pilon,® truRoots,® White Lily,® Martha White,® and Sahale Snacks® in the United States, along with Robin Hood,® Five Roses,® Carnation,® and Bick's® in Canada.


Morgan Stanley & Co. and Centerview Partners acted as financial advisors, and Simpson Thacher & Bartlett LLP acted as legal advisor to Big Heart Pet Brands.

A tonal version of the Vestar Logo on a seafoam colored ground.

ICON to Acquire MediMedia Pharma Solutions

DUBLIN--(BUSINESS WIRE)-- ICON plc (NASDAQ:ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced it has agreed, subject to certain customary closing conditions, to acquire MediMedia Pharma Solutions for a cash consideration of$120 million. MediMedia Pharma Solutions is division of MediMedia USA and is owned by Vestar Capital Partners.

The acquisition strengthens ICON's expertise in scientific communications and market access and, together with ICON's existing Commercialisation and Outcomes practices, creates the industry's leading integrated scientific communications and market access solution.

Headquartered in Yardley, Pennsylvania, MediMedia Pharma Solutions includes MediMedia Managed Markets and Complete Healthcare Communications. MediMedia Managed Markets is a leading provider of strategic payer-validated market access solutions. Complete Healthcare Communications is one of the leading medical and scientific communication agencies working with medical affairs, commercial and brand development teams within life science companies. MediMedia Pharma Solutions has supported hundreds of development launches and in-market products, spanning over 40 therapeutic classes.

Commenting on the acquisition, Ciaran Murray, ICON CEO, said: "The need to demonstrate and communicate the value of new medicines is an important global healthcare trend. Through ICON's market leading commercialisation and outcomes group we are supporting our customers to maximise the value of their new drugs. Our acquisition of MediMedia Pharma Solutions deepens the expertise of this group and brings us outstanding scientific and medical communications capabilities."

Tim Search, President of MediMedia Pharma Solutions, commented, "The combination of the commercial, scientific, and market access expertise of MediMedia Pharma Solutions and ICON creates an unparalleled offering that can inform product investment decisions and establish and communicate product value. With the shift to evidence-based medicine and value-based pricing, we are excited about the expanded expertise and capabilities our relationship with ICON brings to our combined customers."

About ICON plc

ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company specialises in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies. ICON currently has 10,600 employees, operating from 83 locations in 38 countries.

Further information is available at www.iconplc.com

Tervita logo.

Tervita Corporation's U.S.-Based Operations to be Acquired by Republic Services

Tervita, LLC's Vertically Integrated Operations to Serve as Platform for Republic Services' Continued Growth in E&P Sector; Tervita Corporation to Focus on its Growing Canadian Operations

PHOENIX, Dec. 19, 2014 /PRNewswire/ -- Republic Services, Inc. (NYSE: RSG) and Calgary, Alberta-based Tervita Corporation announced today that the companies have entered into a definitive agreement whereby a subsidiary of Republic Services will acquire Tervita, LLC ("Tervita"), a subsidiary of Tervita Corporation. Tervita is a leading pure-play environmental waste solutions provider serving oil and natural gas producers in the United States.

Tervita's geographic footprint spans across some of the most attractive domestic basins, including the Permian, Eagle Ford and Bakken. Tervita provides oilfield waste services to its diverse customer base and operates three types of waste management and disposal facilities: treatment, recovery and disposal (TRD) facilities; engineered landfills; and salt water disposal (SWD) injection wells. Additionally, Tervita provides closed loop solids control systems and transportation services.

"The acquisition of this vertically integrated operation allows Republic Services to establish a significant platform in the E&P waste sector and positions us well for future growth opportunities," said Donald W. Slager, president and CEO of Republic Services. "Additionally, Tervita's environmentally committed operations complement our core competency and expertise in waste handling, recovery and disposal."

"Over the last decade we have built a broad U.S. footprint with a strong reputation for high quality services, a deeply experienced employee base and a strong commitment to safety," said Tervita Corporation President & CEO, John W. Gibson, Jr. "As we now focus our strategic efforts on growing our expansive Canadian operations, we believe that Republic Services, a company with high expertise and integrity, is best positioned to realize Tervita's U.S. growth potential."

Tervita, through its approximately 500-person skilled U.S. workforce, has an exceptional track record of safety and regulatory compliance across its entire operational footprint. Tervita is committed to operational best practices and has reinforced its strong reputation as a reliable, high quality service provider.

J.P. Morgan Securities LLC acted as exclusive financial advisor to Republic Services and Goldman, Sachs & Co. acted as exclusive financial advisor to Tervita Corporation on this transaction.

About Tervita Corporation:
Tervita Corporation is a leading North American environmental solutions provider. Its integrated earth, water, waste and resource solutions deliver safe and efficient results through all phases of a project by minimizing impact, maximizing returns.™ More than 3,000 dedicated employees are trusted sustainability partners to oil and gas, construction, mining, government and communities. Safety is its highest priority: it influences its actions and shapes its culture.

About Republic Services:
Republic Services, Inc. is an industry leader in U.S. non-hazardous recycling and solid waste. Through its subsidiaries, Republic's collection companies, transfer stations, recycling centers and landfills focus on providing reliable environmental services and solutions for commercial, industrial, municipal and residential customers. Republic and its employees believe in protecting the planet and applying common sense solutions to customers' waste and recycling challenges. For more information, visit the Republic website at republicservices.com.

Logo for ISS.

Vestar Portfolio Company Institutional Shareholder Services to Acquire Incentive Lab

Rockville, MD (October 16, 2014) – Institutional Shareholder Services Inc. (“ISS”), a leading provider of corporate governance solutions to the global financial community, today announced the acquisition of the business of Incentive Lab, a data and analytics firm developing innovative solutions for addressing the increased complexity and unpredictability of executive compensation.

Established in 2009 and based in Scottsdale, Arizona, Incentive Lab is unique among providers of executive compensation data and analytics, offering detailed and comparable data on incentive awards, full details on performance metrics, goals, and structures, and a host of other data such as vesting schedules and performance periods. Based on this detailed data, Incentive Lab has developed innovative approaches to value and benchmark performance-based compensation, assess the rigor of performance targets, and understand how changes in plan design impact likely award outcomes.

"This acquisition is in keeping with our commitment to clients to expand product offerings and provide innovative solutions that will improve investment decision-making while mitigating portfolio governance risk,” said ISS President & CEO Gary Retelny. "The breadth and depth of Incentive Lab’s compensation data, coupled with its proprietary approach to measuring the efficacy of the link between pay and performance, will be a powerful tool for ISS' institutional investor clients as well as for the corporate clients of ISS’ ICS subsidiary."

ISS will continue to maintain Incentive Lab operations in Scottsdale and will integrate the firm’s solutions into its industry leading research, data, and analytical tools used by investors and corporations. "We look forward to welcoming the highly talented staff of Incentive Lab into the ISS family,” said Retelny.

"This transaction underscores the importance for both corporations and their shareholders in getting compensation right," said Dr. Carr Bettis, founder, chairman and chief scientist of Incentive Lab. "As the market leader in providing corporate governance solutions, ISS is an ideal home to continue Incentive Lab’s innovative work.”


About ISS

ISS, founded in 1985 as Institutional Shareholder Services Inc., is the world's leading provider of proxy advisory and corporate governance solutions to financial market participants. ISS' services include objective proxy research and analysis, end-to-end proxy voting and distribution solutions, turnkey securities class-action claims management, and reliable governance data and modeling tools. Clients rely on ISS' expertise to help them make informed corporate governance decisions. For more information, please visit www.issgovernance.com.

About Incentive Lab

Incentive Lab is a data and analytics firm created to address the increasing complexity of executive compensation plans. Incentive Lab superior data and essential science provide market-leading expertise in valuing performance-based incentive awards, evaluating the effectiveness of design choices and communicating results. With performance-based compensation now the largest portion of executive pay, Incentive Lab services are helping companies, compensation consultants and others add insight and clarity to executive compensation. For more information, please visit www.incentivelab.com.

Media Contacts (ISS):

Nancy Adler, Head of Marketing & Communications, ISS
[email protected]

Subodh Mishra, Vice President for Communications, ISS
[email protected]

Logo for 21St Century Oncology.

21st Century Oncology Received $325 Million Net Cash Proceeds from Preferred Equity Investment

New investor, Canada Pension Plan Investment Board, is Canada’s largest pension fund manager, with C$227 billion in assets under management

• Investment results in substantial deleveraging, stronger liquidity, and significant capital for continued business expansion
• 21st Century Oncology (21C) to use fresh capital to drive integrated cancer care strategy, organic growth and corporate development initiatives

FORT MYERS, FL & NEW YORK, NY, SEPTEMBER 26, 2014 – 21st Century Oncology Holdings, Inc. (“21st Century Oncology” or “the Company”) and Vestar Capital Partners (“Vestar”) today announced that Canada Pension Plan Investment Board (“CPPIB”), Canada’s largest pension fund manager with C$227 billion in assets under management, has made a $325 million equity investment in the Company. The investment provides the Company with substantial incremental liquidity, enables significant debt reduction, and secures the long-term capital necessary to support the Company’s future growth strategy.

Dr. Daniel Dosoretz, Founder and Chief Executive Officer, said, “This new capital provided by CPPIB is a significant equity investment for 21C. CPPIB’s investment is a key partnership in our worldwide leadership of Integrated Cancer Care (ICC) and our ability to achieve sustained organic and acquisitive growth. We are extremely pleased that CPPIB has joined Vestar Capital as a major equity partner, sharing our conviction that we will continue to leverage our unique global platform and execute our long-term business plan.”

Dr. Dosoretz continued, “Importantly, the investment allows us to continue to pursue our ICC and corporate development strategies that have driven the expansion of our business over the past several years. It will significantly enhance our capital structure and give us the resources necessary to continue providing integrated cancer care, improve the quality of care, and deliver that care at compelling value to our expanding patient population throughout North America and Latin America. Our business continues to perform well, with strong organic trends and growth contributions from the acquisitions of OnCure and SFRO. We expect to continue to build on our second quarter momentum as we move through the second half of 2014, delivering academic quality care to patients, improving census and executing our growth strategy.”

Scott Lawrence, Managing Director, Head of Relationship Investments, CPPIB, said, “We are pleased to become a cornerstone investor in 21C, and we look forward to a strong partnership with senior management and Vestar Capital. This investment is aligned with our goals of providing strategic, longterm capital to industry leading businesses where we can participate in their future success and help create greater value through an ongoing partnership.”

Rob Rosner, Chairman of the Board of 21C and Co-President of Vestar Capital, noted, “The CPPIB investment supports Vestar’s long-term thesis that 21C is the preeminent platform for integrated cancer care and provides academic quality care in comfortable, convenient and integrated settings. We look forward to our partnership with CPPIB in fulfilling the Company’s mission and reaching its full business potential.”

The net proceeds of the investment will be used to repay all outstanding borrowings under the Company’s revolving credit facility of approximately $79.5 million, repay all obligations under the South Florida Radiation Oncology (SFRO) credit facilities of approximately $84.5 million, repay certain other debt and capital leases, fund strategic initiatives, and provide working capital for general corporate purposes. As a result of the CPPIB investment, the recapitalization support agreement that the Company entered into in July has terminated in accordance with its terms. The Company’s senior subordinated notes will remain outstanding and unmodified. Following the repayments of debt identified for repayment, the Company expects to have approximately $80 million of the net cash proceeds on hand.

Pursuant to the terms of the investment, CPPIB will receive shares of the Series A Convertible Preferred Stock and will have the right to nominate two directors for appointment to 21C’s Board of Directors. The holders of a majority of the outstanding preferred stock will have customary consent rights and will be entitled to vote together with the holders of the Company’s common stock on an as converted basis under certain circumstances.

A detailed Form 8-K filing that includes the specifics of the new preferred stock and related documentation is available on the U.S. Securities and Exchange Commission (SEC) website,

Logo for Civitas Solutions.

Civitas Solutions, Inc. (a/k/a National Mentor Holdings) Announces Pricing of Initial Public Offering

Released by Civitas: 09/16/2014
BOSTON--(BUSINESS WIRE)--Civitas Solutions, Inc. (“Civitas” or the “Company”) announced today that it has priced the underwritten initial public offering of 11,700,000 shares of its common stock at a price to the public of $17.00 per share. In connection with the offering, Civitas has granted the underwriters a 30-day option to purchase up to an additional 1,755,000 shares. The shares are expected to begin trading on the New York Stock Exchange beginning on September 17, 2014 and will trade under the symbol “CIVI.” The offering is expected to close on September 22, 2014.

Civitas expects to receive proceeds from this offering, after deducting estimated underwriting discounts and commissions and offering expenses payable by the Company, of approximately $182.2 million. Civitas intends to use the proceeds from this offering, together with cash on hand, to (i) redeem $162.0 million in aggregate principal amount of the senior notes issued by National Mentor Holdings, Inc. at a redemption price of 106.25% plus accrued and unpaid interest thereon to the date of redemption and (ii) pay a transaction advisory fee to its equity sponsor under a management agreement that will terminate upon completion of the offering.

Barclays Capital Inc., BofA Merrill Lynch and UBS Securities LLC are serving as representatives of the underwriters and joint book-running managers for the offering. Raymond James & Associates, Inc., SunTrust Robinson Humphrey, Inc., BMO Capital Markets Corp. and Avondale Partners, LLC are acting as co-managers.


Logo for ISS.

Vestar Capital Partners to Acquire Institutional Shareholder Services from MSCI

Rockville, MD and New York, NY – Institutional Shareholder Services Inc. (“ISS”), a leading provider of corporate governance solutions to the global financial community, today announced its parent company, MSCI Inc. (NYSE: MSCI), had entered into a definitive agreement with Vestar Capital Partners  (“Vestar“), pursuant to which Vestar has agreed to acquire ISS for $364 million. The transaction is expected to close in the second quarter, subject to customary closing conditions.

ISS will operate independently once the transaction is completed. The current ISS executive team will remain in place.

"With Vestar’s support, the management team looks forward to advancing ISS‘ long-standing mission of providing world-class corporate governance solutions in an independent and transparent manner," said Gary Retelny, President of ISS. "Clients will continue to see expanded product offerings, innovative solutions, and the same high level of service that ISS has delivered to institutional investors, corporations, and governance practitioners globally for nearly three decades."

Also commenting on the transaction, Vestar Capital Partners‘ Robert L. Rosner, Founding Partner and Co-President, said ISS‘ position in the industry, future prospects, and strong management team appealed significantly to the New York-based private equity firm.

"This transaction underscores our belief in the importance of corporate governance and ISS‘ leadership position within the industry. ISS is a market leader in providing corporate governance solutions, with strong client retention rates and a powerful commitment to operating impartially. We fully support the ISS management team and its focus on innovation and providing unrivaled client service," said Rosner.

MSCI acquired ISS in 2010 as part of its acquisition of RiskMetrics Group. ISS currently has close to 700 employees operating across 15 global offices in 10 countries.  Its 1,700 clients include institutional investors, who rely on ISS‘ objective and impartial proxy research and data to vote portfolio holdings, as well as corporations focused on governance risk mitigation as a shareholder-value enhancing measure.

Morgan Stanley acted as financial advisor and Davis Polk & Wardwell LLP acted as legal advisor to MSCI on the transaction. Simpson Thacher & Bartlett LLP served as legal advisor to Vestar Capital Partners.



About ISS
ISS, founded in 1985 as Institutional Shareholder Services Inc., is the world's leading provider of proxy advisory and corporate governance solutions to financial market participants. ISS' services include objective proxy research and analysis, end-to-end proxy voting and distribution solutions, turnkey securities class-action claims management, and reliable governance data and modeling tools. Clients rely on ISS' expertise to help them make informed corporate governance decisions.  For more information, please visit www.issgovernance.com.

Logo for Roland.

Vestar Capital Partners Acquires Majority Interest in Roland Foods

NEW YORK, NEW YORK – August 26, 2013 – American Roland Food Corp. (“Roland Foods”) and Vestar Capital Partners (“Vestar”) today announced that Vestar Capital Partners VI, L.P. has signed a definitive agreement to acquire a majority interest in the Roland Foods family of companies, including Bruno Scheidt, Inc., American Roland Food Corp., Pro Warehouse Corp., and Costamar Corp. Terms were not disclosed. The transaction is expected to close by the end of September.

Roland Foods is a recognized leader in the imported specialty foods business in the U.S. and around the globe. “My parents started Roland Foods in the U.S. nearly 75 years ago, and the company has grown consistently over the years with the help of our valued customers, suppliers, and staff,” said Charles E. Scheidt, a member of the company’s founding family and CEO of Roland Foods. “Vestar appreciates and shares our values, as well as our company’s single-minded focus on our brands, quality products, and exceptional and reliable customer service. This evolution enables Roland Foods to build on its excellent foundation.”

“Roland Foods is a great company with a unique niche and superb reputation in the industry, and an exceptional initial investment for our new Vestar VI fund,” said Dan O’Connell, Founder and CEO of Vestar. “Roland Foods is not only performing extremely well but also has impressive potential. Coupled with the bright growth outlook we see in the specialty foods sector, we believe Vestar’s resources and experience in the food and branded products arena can help Roland Foods grow substantially.”

The management team and staff will remain in place. Charlie Scheidt will continue as CEO and Chairman of the Board and will retain a meaningful investment in the company. The company anticipates that a new CEO will be named in the coming year. Roland Foods expects a seamless transition for the suppliers, vendors, and customers, with continuity, stability, and growth being top priorities.

Wells Fargo Securities, LLC acted as the M&A advisor to Vestar in this transaction. Financing for the transaction was provided by BMO Capital Markets and GE Capital Markets. Vestar’s legal advisor was Kirkland & Ellis LLP.

Evercore Partners served as financial advisor to American Roland Food Corp. and McDermott Will & Emery LLP served as legal advisor.

About Roland Foods

Roland Foods, based in New York City, specializes in importing high-quality specialty food products from more than 40 countries. Founded in Paris in 1934 and established in the U.S. in 1939, Roland Foods has provided customers with exceptional specialty foods, under the Roland brand as well as the Don Bruno, Chef Susanna’s, Costamar, and Consul brands. The company has a national presence in the foodservice, retail, and industrial channels as well as international sales in the Caribbean, Central and South America, Asia, Africa, and the Middle East. Roland Foods’ dedication to providing quality and consistency has made it a leader among food importers and suppliers. The Roland brand is synonymous with quality for the consumer and chef alike. For more information about American Roland Food Corp., please visit www.rolandfood.com.

About Vestar Capital Partners

Vestar Capital Partners is a leading U.S. middle-market private equity firm specializing in management buyouts and growth capital investments. Vestar invests and collaborates with incumbent management teams and private owners in a creative, flexible and entrepreneurial way to build long-term enterprise value.

Vestar is targeting equity investments in the range of $50 million to $200 million in U.S.-based middle-market companies with enterprise values ranging from $100 million to $1 billion. Vestar has extensive experience investing across a wide variety of industries including Consumer, Healthcare, Digital Media, Information Services, Diversified Industries, and Financial Services.

Since Vestar’s founding in 1988, Vestar funds have completed 70 investments in companies with a total value of more than $40 billion. For more information, please visit www.vestarcapital.com.



Carol Makovich
Owen Blicksilver Public Relations
(203) 622-4781
[email protected]

Jennifer Hurson
(845) 507-0571
[email protected]

Tervita logo.

Vestar Portfolio Company Tervita Closes $850M Refinancing

by Kirk Falconer

CALGARY, ALBERTA (February 14, 2013) - Vestar portfolio company Tervita Corporation announced today the closing of a US$650 million offering of Senior Secured Notes due 2018 and CDN$200 million in Senior Secured Notes due 2018 (collectively, the "Senior Secured Notes") in a private placement.

"These refinancings are the culmination of a process that began more than a year ago," said John Gibson, Tervita president and CEO. "We have now refinanced or extended the maturity of a significant majority of all of our debt to 2018-2019, which we believe will support the long-term growth of our business."

The Senior Secured Notes were issued pursuant to an indenture dated as of February 14, 2013, by and among Tervita Corporation, the guarantors named therein and Wells Fargo, National Association, as U.S. trustee and Equity Financial Trust Company, as Canadian Trustee.

Concurrently with the closing of the Senior Secured Notes offering, Tervita amended and restated its existing senior secured term loan agreement and entered into a new senior secured revolving credit facility. Tervita has also negotiated certain amendments to its existing senior subordinated notes, including an extension of the maturity of these notes to November 15, 2018 in conjunction with this financing.

The Senior Secured Notes were offered and sold only to qualified institutional buyers in accordance with Rule 144A under the United States Securities Act of 1933, as amended (the "Securities Act") and outside the United States to persons other than U.S. persons in reliance on the "accredited investor" prospectus exemption in Canada and Regulation S under the Securities Act. The offer and sale of the Senior Secured Notes have not been and will not be registered under the Securities Act and the Senior Secured Notes may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and applicable state securities laws.

This press release does not constitute an offer to sell or purchase, or a solicitation of an offer to sell or purchase, or the solicitation of tenders or consents with respect to any security. No offer, solicitation, purchase or sale will be made in any jurisdiction in which such an offer, solicitation, or sale would be unlawful.

Cautionary Statement on Forward-Looking Statements

This press release contains forward-looking statements. The forward-looking statements contained herein include statements about our expectations for the proposed debt financing and our ability to successfully effect the foregoing. These statements are subject to the general risks inherent in our business and in the credit markets and reflect our current expectations regarding these matters. These expectations may or may not be realized. Some of these expectations may be based upon assumptions or judgments that prove to be incorrect. The forward-looking statements are only as of the date made, and Tervita Corporation does not undertake any obligation to (and expressly disclaims any obligation to) update any forward-looking statements to reflect events or circumstances after the date such statements were made, or to reflect the occurrence of unanticipated events.

For more information, or to speak to a Tervita representative, please contact:

Richard Brimble
VP, Finance & Treasurer
[email protected]
T: (403) 234-2097
M: (403) 828-9534

Mandy Dinning
[email protected]
T: (403) 718-1221

About Tervita

Tervita is a leading North American environmental and energy services company. More than 4,000 dedicated employees partner with natural resource and industrial companies who share our values, and work with them to create a sustainable future. Safety is our highest priority: it influences our actions, guides our decisions and shapes our culture. We maintain a strategically located network of more than 95 state-of-the-art waste management facilities and a fleet of specialized equipment and assets to help customers address production and operational waste challenges. Our highly effective, convenient and environmentally sound solutions help minimize environmental impact and maximize returns. www.tervita.com

Logo for Sunrise Medical.

Vestar Capital Partners Completes Sale of Sunrise Medical

NEW YORK, NEW YORK - December 6, 2012 - Vestar Capital Partners ("Vestar") announced the completion of the sale of Sunrise Medical Inc. ("Sunrise Medical") to funds advised by Equistone Partners Europe.

Sunrise Medical is the leading global manufacturer, marketer and distributor of high-end custom manual and power wheelchairs and technologically advanced and proprietary seating systems. Terms of the transaction, which was previously announced on November 6, 2012, were not disclosed.

"Our teamwork with Sunrise Medical management produced successful spin-offs, turned the company around and brought us to this highly satisfactory outcome for Vestar and its investors," said Dan O'Connell, CEO of Vestar.

"This successful Sunrise Medical transaction is the latest is a series of activities focused on creating portfolio value and delivering on a program of realizations for our limited partners," Mr. O'Connell said. "In just the last year, we have returned approximately $900 million from six investments to our investors. Since 2009, we have returned approximately $2.3 billion from 13 investments."

Sunrise Medical and Vestar received financial advice from Rothschild. Simpson Thacher & Bartlett LLP provided legal counsel and Deloitte Tax LLP provided tax advice. Equistone received financial advice from Hauck & Aufhäuser. P+P Pöllath + Partners and Thompson Hine LLP provided legal advice. Ashurst advised on credit documentation and KPMG provided tax advice.

About Vestar Capital Partners

Vestar Capital Partners is a leading private equity firm specializing in management buyouts and growth capital investments. Vestar’s active funds aggregate approximately $8 billion in commitments. The firm targets companies in North America with valuations of $150 million to $1.5 billion in four key industry sectors: Consumer, Diversified Industries, Healthcare, and Financial Services. Vestar invests and collaborates with incumbent management teams, family owners or corporations in a creative, flexible and entrepreneurial way to build long-term enterprise value. Since the firm’s founding in 1988, the Vestar funds have completed 69 investments in companies with a total value of more than $30 billion. For more information, please visit www.vestarcapital.com

For Vestar Capital Partners
Owen Blicksilver Public Relations
Carol Makovich
(203) 940-2257
[email protected]

Jennifer Hurson
(845) 507-0571
[email protected]